Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
04
2020
accepted:
25
06
2020
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
22
9
2020
Statut:
epublish
Résumé
To develop and validate a machine-learning algorithm to improve prediction of incident OUD diagnosis among Medicare beneficiaries with ≥1 opioid prescriptions. This prognostic study included 361,527 fee-for-service Medicare beneficiaries, without cancer, filling ≥1 opioid prescriptions from 2011-2016. We randomly divided beneficiaries into training, testing, and validation samples. We measured 269 potential predictors including socio-demographics, health status, patterns of opioid use, and provider-level and regional-level factors in 3-month periods, starting from three months before initiating opioids until development of OUD, loss of follow-up or end of 2016. The primary outcome was a recorded OUD diagnosis or initiating methadone or buprenorphine for OUD as proxy of incident OUD. We applied elastic net, random forests, gradient boosting machine, and deep neural network to predict OUD in the subsequent three months. We assessed prediction performance using C-statistics and other metrics (e.g., number needed to evaluate to identify an individual with OUD [NNE]). Beneficiaries were stratified into subgroups by risk-score decile. The training (n = 120,474), testing (n = 120,556), and validation (n = 120,497) samples had similar characteristics (age ≥65 years = 81.1%; female = 61.3%; white = 83.5%; with disability eligibility = 25.5%; 1.5% had incident OUD). In the validation sample, the four approaches had similar prediction performances (C-statistic ranged from 0.874 to 0.882); elastic net required the fewest predictors (n = 48). Using the elastic net algorithm, individuals in the top decile of risk (15.8% [n = 19,047] of validation cohort) had a positive predictive value of 0.96%, negative predictive value of 99.7%, and NNE of 104. Nearly 70% of individuals with incident OUD were in the top two deciles (n = 37,078), having highest incident OUD (36 to 301 per 10,000 beneficiaries). Individuals in the bottom eight deciles (n = 83,419) had minimal incident OUD (3 to 28 per 10,000). Machine-learning algorithms improve risk prediction and risk stratification of incident OUD in Medicare beneficiaries.
Identifiants
pubmed: 32678860
doi: 10.1371/journal.pone.0235981
pii: PONE-D-20-09504
pmc: PMC7367453
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0235981Subventions
Organisme : NIDA NIH HHS
ID : R01 DA044985
Pays : United States
Déclaration de conflit d'intérêts
We have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Kwoh has received honoraria from AbbVie and EMD Serono and has provided consulting services for Astellas, Thusane, and Novartis, EMD Serono and Express Scripts. I confirm that this does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
JAMA. 2019 Feb 12;321(6):609-611
pubmed: 30747958
Pain Med. 2005 Nov-Dec;6(6):432-42
pubmed: 16336480
Acad Emerg Med. 2017 Apr;24(4):475-483
pubmed: 27763703
J Community Hosp Intern Med Perspect. 2012 Apr 30;2(1):
pubmed: 23882354
N Engl J Med. 2016 Jan 14;374(2):154-63
pubmed: 26760086
JAMA. 2008 Dec 10;300(22):2613-20
pubmed: 19066381
Ann Intern Med. 2010 Jan 19;152(2):85-92
pubmed: 20083827
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):1917-1923
pubmed: 31937665
Biom J. 2005 Aug;47(4):458-72
pubmed: 16161804
Am J Public Health. 2016 Nov;106(11):1918-1919
pubmed: 27715305
JAMA Netw Open. 2019 Mar 1;2(3):e190968
pubmed: 30901048
J Pain. 2015 Apr;16(4):380-7
pubmed: 25640294
BioData Min. 2019 Jan 29;12:3
pubmed: 30728857
Med Care. 2012 Jun;50(6):494-500
pubmed: 22410408
J Hosp Med. 2014 Feb;9(2):73-81
pubmed: 24227700
Am J Manag Care. 2009 Dec;15(12):897-906
pubmed: 20001171
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519
Pain. 2010 Aug;150(2):332-339
pubmed: 20554392
Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):62-69
pubmed: 29687539
Drug Alcohol Depend. 2008 Apr 1;94(1-3):38-47
pubmed: 18063321
N Engl J Med. 2002 Jan 24;346(4):250-5
pubmed: 11807149
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358
pubmed: 29596405
Am J Med. 2016 Jul;129(7):699-705.e4
pubmed: 26968469
JAMA Intern Med. 2015 Jun;175(6):978-87
pubmed: 25895077
Am J Public Health. 2018 Dec;108(12):1675-1681
pubmed: 30359112
BMC Health Serv Res. 2006 Apr 04;6:46
pubmed: 16595013
Pain. 2013 Nov;154(11):2287-2296
pubmed: 23792283
J Manag Care Spec Pharm. 2014 May;20(5):439-46c
pubmed: 24761815
Am J Med. 2017 Mar;130(3):e113
pubmed: 28215952
JAMA. 2019 Nov 19;322(19):1912-1913
pubmed: 31600370
J Am Med Inform Assoc. 2017 Nov 01;24(6):1204-1210
pubmed: 29016967
PLoS One. 2013;8(2):e54496
pubmed: 23405084
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):521-32
pubmed: 21862719
Subst Abus. 2015;36(2):192-202
pubmed: 25671499
Crit Care. 2015 Aug 13;19:285
pubmed: 26268570
Artif Intell Med. 2008 Mar;42(3):247-59
pubmed: 18063351
J Thorac Oncol. 2011 Sep;6(9):1481-7
pubmed: 21792073
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Med Care. 2017 Mar;55(3):291-298
pubmed: 27984346
JAMA. 2019 Jun 4;321(21):2059-2062
pubmed: 31034007
Med Care. 2017 Dec;55(12):e104-e112
pubmed: 29135773
Drug Saf. 2012 Apr 1;35(4):325-34
pubmed: 22339505
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806
PLoS One. 2016 May 27;11(5):e0155705
pubmed: 27232332
Pain Med. 2012 Sep;13(9):1162-73
pubmed: 22845054
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):39-45
pubmed: 21098782